A citation-based method for searching scientific literature

Stephen M Ansell, Alexander M Lesokhin, Ivan Borrello, Ahmad Halwani, Emma C Scott, Martin Gutierrez, Stephen J Schuster, Michael M Millenson, Deepika Cattry, Gordon J Freeman, Scott J Rodig, Bjoern Chapuy, Azra H Ligon, Lili Zhu, Joseph F Grosso, Su Young Kim, John M Timmerman, Margaret A Shipp, Philippe Armand. N Engl J Med 2015
Times Cited: 2238



Margaretha G M Roemer, Ranjana H Advani, Azra H Ligon, Yasodha Natkunam, Robert A Redd, Heather Homer, Courtney F Connelly, Heather H Sun, Sarah E Daadi, Gordon J Freeman, Philippe Armand, Bjoern Chapuy, Daphne de Jong, Richard T Hoppe, Donna S Neuberg, Scott J Rodig, Margaret A Shipp. J Clin Oncol 2016
Times Cited: 404




List of shared articles



Times cited

Association of PD-L1 and IDO1 expression with JAK-STAT pathway activation in soft-tissue leiomyosarcoma.
Takeshi Iwasaki, Kenichi Kohashi, Yu Toda, Shin Ishihara, Yuichi Yamada, Yoshinao Oda. J Cancer Res Clin Oncol 2021
1

The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker.
Denis L Jardim, Aaron Goodman, Debora de Melo Gagliato, Razelle Kurzrock. Cancer Cell 2021
32

Novel Therapies in the Treatment of Hodgkin Lymphoma.
Xavier Andrade-Gonzalez, Stephen M Ansell. Curr Treat Options Oncol 2021
1

Early Evaluation of Immunotherapy Response in Lymphoma Patients by 18F-FDG PET/CT: A Literature Overview.
Cristina Ferrari, Nicola Maggialetti, Tamara Masi, Anna Giulia Nappi, Giulia Santo, Artor Niccoli Asabella, Giuseppe Rubini. J Pers Med 2021
3

Immune Microenvironment Features and Dynamics in Hodgkin Lymphoma.
Clara Bertuzzi, Elena Sabattini, Claudio Agostinelli. Cancers (Basel) 2021
0

Checkpoint Inhibitors in Relapsed/Refractory Classical Hodgkin Lymphoma.
Kidist Tarekegn, Ana Colon Ramos, Balraj Singh, Harry G Sequeira Gross, Sachin Gupta. World J Oncol 2021
0

Synchronizing the use of allogeneic hematopoietic cell transplantation in checkpoint blockade therapy for Hodgkin lymphoma.
Alberto Mussetti, Anna Bosch Vilaseca, Rocío Parody, Annalisa Paviglianiti, Eva Domingo-Domenech, Ana Maria Sureda. Expert Rev Hematol 2021
0


Hodgkin Lymphoma: A Special Microenvironment.
Giuseppina Opinto, Claudio Agostinelli, Sabino Ciavarella, Attilio Guarini, Eugenio Maiorano, Giuseppe Ingravallo. J Clin Med 2021
0

Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma.
Gabriel K Griffin, Jason L Weirather, Margaretha G M Roemer, Mikel Lipschitz, Alyssa Kelley, Pei-Hsuan Chen, Daniel Gusenleitner, Erin Jeter, Christine Pak, Evisa Gjini,[...]. Blood 2021
6

Immune landscape and therapeutic strategies: new insights into PD-L1 in tumors.
Yuan Wei, Xiao Xiao, Xiang-Ming Lao, Limin Zheng, Dong-Ming Kuang. Cell Mol Life Sci 2021
1

Regulation of PD-L1 expression in the tumor microenvironment.
Ming Yi, Mengke Niu, Linping Xu, Suxia Luo, Kongming Wu. J Hematol Oncol 2021
20

Biology in Practice: Harnessing the Curative Potential of the Immune System in Lymphoid Cancers.
Tomohiro Aoki, Kerry J Savage, Christian Steidl. J Clin Oncol 2021
1


The evolving paradigm of biomarker actionability: Histology-agnosticism as a spectrum, rather than a binary quality.
Paolo Tarantino, Luca Mazzarella, Antonio Marra, Dario Trapani, Giuseppe Curigliano. Cancer Treat Rev 2021
1

The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA.
Lieselot Buedts, Iwona Wlodarska, Julio Finalet-Ferreiro, Olivier Gheysens, Luc Dehaspe, Thomas Tousseyn, Luc-Matthieu Fornecker, Julien Lazarovici, René-Olivier Casasnovas, Anne-Claire Gac,[...]. Blood Adv 2021
0